Oral pre-exposure prophylaxis (PrEP) is the use of oral antiretroviral medications by HIV-negative individuals to prevent HIV acquisition. In Lesotho, where adult HIV prevalence and incidence are among the highest in the world, the Ministry of Health and Social Welfare has incorporated oral PrEP into its HIV prevention policy for high-risk populations. To inform scale-up, HP+ used a new mathematical modeling approach to estimate the impact and cost-effectiveness of different rollout scenarios to various segments of the population. In addition to the brief, findings from the modeling were presented as a poster at the 2018 HIV Research for Prevention Conference.
Health Policy Plus. 2018. Oral Pre-Exposure Prophylaxis Modeling Results: Lesotho. Washington, DC: Palladium, Health Policy Plus.
English PDF 511.6 kbNovember 2018
Information presented on this website is considered public information and may be distributed or copied freely unless identified as being subject to copyright protection.